Last updated on December 2019

A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

Brief description of study

This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration resistant prostate cancer.

Clinical Study Identifier: NCT03706365

Find a site near you

Start Over

Norton Cancer Institute

Louisville, KY United States
  Connect »